CUL4B
protein-codingcullin 4B, the group of Cullins
Gene summary
This gene is a member of the cullin family. The encoded protein forms a complex that functions as an E3 ubiquitin ligase and catalyzes the polyubiquitination of specific protein substrates in the cell. The protein interacts with a ring finger protein, and is required for the proteolysis of several regulators of DNA replication including chromatin licensing and DNA replication factor 1 and cyclin E. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~98.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010306
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010306
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0010306
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0010306
Submitter: ClinGen
*CUL4B* was first reported in relation to X-linked intellectual disability, Cabezas type in 2007 (Tarpey et al., PMID: 17236139). CUL4B is a member of the cullin family of proteins that function as scaffold proteins for multiple ubiquitin-protein ligase complexes that regulate the degradation of target proteins. The reported phenotypes in affected males include intellectual disability, hypogonadism, delayed puberty, short stature, relative macrocephaly, central obesity, dysmorphic features, aggressive outbursts, tremor, seizures, and variable cerebral malformations (PMIDs: 17236139, 25385192). Carrier females have skewed X-chromosome inactivation and are unaffected. Six variants (splice, nonsense, frameshift) that have been reported in seven probands in three publications (PMIDs: 17236139, 17273978, 24898194) are included in this curation. Variants in this gene segregated with disease in additional family members. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is reported to be loss of function. This gene-disease relationship is also supported by a mouse model (PMID: 22763239). In summary, there is definitive evidence supporting the relationship between *CUL4B* and X-linked intellectual disability, Cabezas type. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on February 21, 2018 (SOP Version 5). As of October 2025, this record underwent administrative updates to include an evidence summary text and update scoring to be consistent with SOP Version 11. No new evidence has been added.
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Endocrine; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CUL4B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001079872.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 13 | 106 | 4 | 124 | |
| missense | 2 | 5 | 250 | 10 | 3 | 270 |
| nonsense | 11 | 8 | 15 | 34 | ||
| start loss | 0 | |||||
| frameshift | 18 | 11 | 1 | 30 | ||
| splice donor/acceptor (+/-2bp) | 6 | 6 | 34 | 46 | ||
| Total | 37 | 31 | 313 | 116 | 7 | 504 |
Highest pathogenic variant AF is 0.000044694032
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001073341.1 | 20 | MANE Select | |
| Ensembl | ENSP00000360373.5 | 20 | MANE Select | |
| RefSeq | NP_001317553.1 | 21 | Standard | |
| RefSeq | NP_001356074.1 | 20 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Nucleotide excision repair - Homo sapiens (human)
- Ubiquitin mediated proteolysis - Homo sapiens (human)
- miR-targeted genes in epithelium - TarBase
- miR-targeted genes in lymphocytes - TarBase
- miR-targeted genes in muscle cell - TarBase
Biological Process
- G1/S transition of mitotic cell cycle
- nucleotide-excision repair, DNA damage recognition
- transcription-coupled nucleotide-excision repair
- nucleotide-excision repair, preincision complex stabilization
- nucleotide-excision repair, preincision complex assembly
Molecular Function
- damaged DNA binding
- protein binding
- ubiquitin protein ligase binding
- ubiquitin protein ligase activity
Cellular Component
- nucleoplasm
- cytosol
- SCF ubiquitin ligase complex
- cullin-RING ubiquitin ligase complex
- Cul4B-RING E3 ubiquitin ligase complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000404115
- Coding exons
- 21
- Length
- 51186
- Individuals with no LoFs
- 125727
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 3
- Defined
- 125730
- p
- 0.0000119
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.77 | 126 | 314 | 0.401 | 0.0000218 | 6077 |
| Missense (PolyPhen) | 10 | 77.472 | 0.12908 | 1547 | ||
| Synonymous | -0.522 | 119 | 112 | 1.06 | 0.00000790 | 1628 |
| Loss of Function | 5.48 | 0 | 35.0 | 0.00 | 0.00000254 | 642 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00038 | 0.00018 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Core component of multiple cullin-RING-based E3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins. The functional specificity of the E3 ubiquitin-protein ligase complex depends on the variable substrate recognition subunit. CUL4B may act within the complex as a scaffold protein, contributing to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme. Plays a role as part of the E3 ubiquitin-protein ligase complex in polyubiquitination of CDT1, histone H2A, histone H3 and histone H4 in response to radiation- induced DNA damage. Targeted to UV damaged chromatin by DDB2 and may be important for DNA repair and DNA replication. Required for ubiquitination of cyclin E, and consequently, normal G1 cell cycle progression. Regulates the mammalian target-of-rapamycin (mTOR) pathway involved in control of cell growth, size and metabolism. Specific CUL4B regulation of the mTORC1-mediated pathway is dependent upon 26S proteasome function and requires interaction between CUL4B and MLST8. {ECO:0000269|PubMed:14578910, ECO:0000269|PubMed:16322693, ECO:0000269|PubMed:16678110, ECO:0000269|PubMed:18235224, ECO:0000269|PubMed:18593899, ECO:0000269|PubMed:19801544, ECO:0000269|PubMed:22118460}.;
- Disease
- DISEASE: Mental retardation, X-linked, syndromic, 15 (MRXS15) [MIM:300354]: A syndromic form of X-linked mental retardation characterized by severe intellectual deficit associated with short stature, craniofacial dysmorphism, small testes, muscle wasting in lower legs, kyphosis, joint hyperextensibility, pes cavus, small feet, and abnormalities of the toes. Additional neurologic manifestations include speech delay and impairment, tremor, seizures, gait ataxia, hyperactivity and decreased attention span. {ECO:0000269|PubMed:17236139, ECO:0000269|PubMed:17273978, ECO:0000269|PubMed:19377476, ECO:0000269|PubMed:20002452}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.121
Intolerance Scores
- RVIS EVS
- -0.36
- RVIS percentile EVS
- 28.63
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.559
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |